Is a complete OCS research report available?

No complete published report is available for Oculis Holding AG (OCS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Oculis Holding AG (OCS)

NASDAQ: OCS · USD

$7.94

+0.11 (+1.4%)· Recorded snapshot

Market cap	490.2M
Revenue (ttm)	1.5M
Net income (ttm)	-98M
EPS (ttm)	-$1.72
Shares out	61.7M
Volume	183,168
Beta	0.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.5M
Net income (ttm): -98M
EPS (ttm): -$1.72
Market cap: 490.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0001953530
Company name	Oculis Holding AG
Country	Switzerland
Country code	US
Earnings date	2026-11-03
Earnings time	amc
Employees	60
Employees change	11
Employees growth	22.45%
Enterprise value	$210.7M
Exchange	NASDAQ
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2003
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	CH1242303498
Last 10-K release date	2026-03-04
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$490.2M
Market cap category	Small-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$7.94
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	OCS
Website	https://oculis.com

Metric

Value

Amount currency

USD

CIK code

0001953530

Company name

Oculis Holding AG

Country

Switzerland

Country code

Earnings date

2026-11-03

Earnings time

amc

Employees

Employees change

Employees growth

22.45%

Enterprise value

$210.7M

Exchange

NASDAQ

Financial currency

CHF

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2003

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

CH1242303498

Last 10-K release date

2026-03-04

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$490.2M

Market cap category

Small-Cap

Next earnings date

2026-11-03

Options

Yes

Price

$7.94

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

OCS

Website

https://oculis.com

Metric	Value
Earnings yield	-21.6%
EV/Sales	145.58x
FCF / EV yield	-37.54%
FCF yield	-16.16%
Forward EV/Sales	401.54x
Forward P/S	932.45x
P/B ratio	1.78x
P/S ratio	338.06x
Price / tangible book value	1.92x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-21.6%

EV/Sales

145.58x

FCF / EV yield

-37.54%

FCF yield

-16.16%

Forward EV/Sales

401.54x

Forward P/S

932.45x

P/B ratio

1.78x

P/S ratio

338.06x

Price / tangible book value

1.92x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Operating margin	-7,350.81%
Pretax margin	-6,773.31%
Profit per employee	$-1.6M
Revenue per employee	$24,196
ROA	-24.95%
ROA (5Y)	-34.05%
ROCE	-38.77%
ROE	-43.7%
ROIC	-29.45%
SBC / revenue	1,749.19%
Tax / revenue	-22.25%

Metric

Value

Operating margin

-7,350.81%

Pretax margin

-6,773.31%

Profit per employee

$-1.6M

Revenue per employee

$24,196

ROA

-24.95%

ROA (5Y)

-34.05%

ROCE

-38.77%

ROE

-43.7%

ROIC

-29.45%

SBC / revenue

1,749.19%

Tax / revenue

-22.25%

Metric	Value
EPS growth quarters	5
EPS growth years	3
Net income growth quarters	4
Net income growth years	0
Revenue growth	53.53%
Revenue growth (Q)	18.77%
Revenue growth (QoQ)	48.33%
Revenue growth 3Y	9.44%
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

53.53%

Revenue growth (Q)

18.77%

Revenue growth (QoQ)

48.33%

Revenue growth 3Y

9.44%

Revenue growth years

Metric	Value
Capital expenditures	$-220,440
Depreciation and amortization	$298,739
EBIT	$-106.7M
EBITDA	$-106.4M
EPS	$-1.72
FCF per share	$-1.29
Financing cash flow	$162.3M
Free cash flow	$-79.3M
Free cash flow minus SBC	$-104M
Gross profit	$-68.8M
Income taxes	$-323,020
Investing cash flow	$-85.6M
Net borrowing	$-533,635
Net cash flow	$-3.3M
Net income	$-98M
Operating cash flow minus SBC	$-103.8M
Operating income	$-106.7M
Revenue	$1.5M
Stock-based compensation	$25.4M

Metric

Value

Capital expenditures

$-220,440

Depreciation and amortization

$298,739

EBIT

$-106.7M

EBITDA

$-106.4M

EPS

$-1.72

FCF per share

$-1.29

Financing cash flow

$162.3M

Free cash flow

$-79.3M

Free cash flow minus SBC

$-104M

Gross profit

$-68.8M

Income taxes

$-323,020

Investing cash flow

$-85.6M

Net borrowing

$-533,635

Net cash flow

$-3.3M

Net income

$-98M

Operating cash flow minus SBC

$-103.8M

Operating income

$-106.7M

Revenue

$1.5M

Stock-based compensation

$25.4M

Metric	Value
Altman Z-Score	16.53
Book value per share	$4.40
Debt / equity	0.01
Interest coverage	-97.43
Long-term assets	$29.1M
Long-term liabilities	$4.7M
Net cash (debt)	$279.4M
Net cash / market cap	56.94%
Net cash growth	41.76%
Net debt / equity	-1.03
Piotroski F-Score	4
Property, plant and equipment	$3.8M
Shareholders' equity	$271.5M
Tangible book value	$255M
Tangible book value per share	$4.13
Total assets	$309.8M
Total cash	$282.6M
Total debt	$3.1M
Total liabilities	$38.4M
WACC	5.85%

Metric

Value

Altman Z-Score

16.53

Book value per share

$4.40

Debt / equity

0.01

Interest coverage

-97.43

Long-term assets

$29.1M

Long-term liabilities

$4.7M

Net cash (debt)

$279.4M

Net cash / market cap

56.94%

Net cash growth

41.76%

Net debt / equity

-1.03

Piotroski F-Score

Property, plant and equipment

$3.8M

Shareholders' equity

$271.5M

Tangible book value

$255M

Tangible book value per share

$4.13

Total assets

$309.8M

Total cash

$282.6M

Total debt

$3.1M

Total liabilities

$38.4M

WACC

5.85%

Metric	Value
Asset turnover	0.01
Current assets	$280.7M
Current liabilities	$33.6M
Current ratio	8.35
Net working capital	$-27.8M
Quick ratio	8.24
Working capital	$253.9M
Working capital turnover	0.01

Metric

Value

Asset turnover

0.01

Current assets

$280.7M

Current liabilities

$33.6M

Current ratio

8.35

Net working capital

$-27.8M

Quick ratio

8.24

Working capital

$253.9M

Working capital turnover

0.01

Metric	Value
Buyback yield / dilution	-23.5%
Dividend yield	0%
Shareholder yield	-23.5%

Metric

Value

Buyback yield / dilution

-23.5%

Dividend yield

Shareholder yield

-23.5%

Metric	Value
150-day SMA	$16.20
1D price change	1.4%
1M price change	-14.78%
1M total return	-14.78%
1W price change	5.47%
1W total return	5.47%
1Y price change	-63.35%
1Y return CAGR	-63.37%
1Y total return	-63.35%
20-day SMA	$8.00
200-day SMA	$18.97
3M price change	-28.31%
3M total return	-28.31%
3Y price change	-17.19%
3Y return CAGR	-6.09%
3Y total return	-17.19%
50-day SMA	$9.95
50-day SMA vs 200-day SMA	50under200
52-week high	$34.48
52-week high date	2026-05-11
52-week low	$7.11
52-week low date	2026-10-14
5Y price change	-18.64%
5Y return CAGR	-4.04%
5Y total return	-18.64%
6M price change	-70.87%
6M total return	-70.87%
All-time high	$34.48
All-time high date	2026-05-11
All-time low	$6.26
All-time low date	2023-03-27
Average true range (ATR)	$0.47
Average volume	330.7K
Beta (1Y)	2.42
Beta (2Y)	0.98
Beta (5Y)	0.27
Change from 52-week high	-76.97%
Change from 52-week low	11.67%
Change from all-time high	-77.08%
Change from all-time low	26.2%
Change from open	-0.13%
Day's gap	1.53%
Dollar volume	$1.5M
High price	$7.97
Low price	$7.88
Monthly RSI	35.48
Open price	$7.95
Position in 52-week range	66.67%
Premarket change	1.92%
Premarket close	$7.83
Premarket price	$7.98
Previous close	$7.83
Price vs 150-day SMA	-51.24%
Price vs 20-day SMA	-1.25%
Price vs 200-day SMA	-58.36%
Price vs 50-day SMA	-20.62%
Relative volume	0.55
RSI	38.62
Sharpe ratio	-1.18
Sharpe ratio (3Y)	0.07
Sortino ratio	-1.32
Sortino ratio (3Y)	0.2
Volume	183.2K
Weekly RSI	29.76
YTD price change	-60.44%
YTD total return	-60.44%

Metric

Value

150-day SMA

$16.20

1D price change

1.4%

1M price change

-14.78%

1M total return

-14.78%

1W price change

5.47%

1W total return

5.47%

1Y price change

-63.35%

1Y return CAGR

-63.37%

1Y total return

-63.35%

20-day SMA

$8.00

200-day SMA

$18.97

3M price change

-28.31%

3M total return

-28.31%

3Y price change

-17.19%

3Y return CAGR

-6.09%

3Y total return

-17.19%

50-day SMA

$9.95

50-day SMA vs 200-day SMA

50under200

52-week high

$34.48

52-week high date

2026-05-11

52-week low

$7.11

52-week low date

2026-10-14

5Y price change

-18.64%

5Y return CAGR

-4.04%

5Y total return

-18.64%

6M price change

-70.87%

6M total return

-70.87%

All-time high

$34.48

All-time high date

2026-05-11

All-time low

$6.26

All-time low date

2023-03-27

Average true range (ATR)

$0.47

Average volume

330.7K

Beta (1Y)

2.42

Beta (2Y)

0.98

Beta (5Y)

0.27

Change from 52-week high

-76.97%

Change from 52-week low

11.67%

Change from all-time high

-77.08%

Change from all-time low

26.2%

Change from open

-0.13%

Day's gap

1.53%

Dollar volume

$1.5M

High price

$7.97

Low price

$7.88

Monthly RSI

35.48

Open price

$7.95

Position in 52-week range

66.67%

Premarket change

1.92%

Premarket close

$7.83

Premarket price

$7.98

Previous close

$7.83

Price vs 150-day SMA

-51.24%

Price vs 20-day SMA

-1.25%

Price vs 200-day SMA

-58.36%

Price vs 50-day SMA

-20.62%

Relative volume

0.55

RSI

38.62

Sharpe ratio

-1.18

Sharpe ratio (3Y)

0.07

Sortino ratio

-1.32

Sortino ratio (3Y)

0.2

Volume

183.2K

Weekly RSI

29.76

YTD price change

-60.44%

YTD total return

-60.44%

Metric	Value
Float	52.4M
Float percentage	84.87%
Shares change (QoQ)	4.02%
Shares change (YoY)	23.5%
Shares held by insiders	3.87%
Shares held by institutions	35.28%
Shares outstanding	61.7M
Short % of float	3.38%
Short % of shares	2.87%
Short ratio	8.2 days

Metric

Value

Float

52.4M

Float percentage

84.87%

Shares change (QoQ)

4.02%

Shares change (YoY)

23.5%

Shares held by insiders

3.87%

Shares held by institutions

35.28%

Shares outstanding

61.7M

Short % of float

3.38%

Short % of shares

2.87%

Short ratio

8.2 days

Oculis Holding AG (OCS)

Price

Financial snapshot

Fair-value bridge

Latest news · OCS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OCS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OCS

Frequently asked questions